HALP score can predict the no-reflow phenomenon and in-hospital mortality after saphenous vein graft intervention

Ömer Furkan Demir; Barış Şensoy

Makale detayları

HALP score can predict the no-reflow phenomenon and in-hospital mortality after saphenous vein graft intervention

Yazarlar:

Ömer Furkan Demir | Barış Şensoy

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kardiyoloji

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

10/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001338821

pISSN:

2718-0115

Anahtar kelimeler:

Özet:

 Aims: The no-reflow phenomenon NRP is one of the most frequently observed complications in saphenous vein graft SVG interventions. The aim of this study was to investigate the effect of the hemoglobin, albumin, lymphocyte, and platelet HALP score on the development of NRP in patients with acute coronary syndrome ACS undergoing percutaneous SVG intervention. Methods: This retrospective study included 263 patients who applied to our center with the diagnosis of ACS and underwent saphenous vein grafting procedure. The patients were divided into two groups according to whether no-reflow developed or not, and the HALP scores of the groups were compared. In addition, in-hospital mortality was compared between the study groups according to their HALP score values. The predictive ability of the HALP score for no-reflow was evaluated using a receiver operating characteristic curve. Results: NRP developed in 103 39.2 of the patients included in the study patients. HALP score value was found to be significantly lower in the no-reflow group 45.320 vs 53.818, p:0.001. In the receiver operating characteristic ROC analysis, the cutoff value for the HALP score was calculated as 46.5. After multivariable adjustment, the HALP score 46.5 was an independent predictor of no-reflow OR4.95, 95 CI:2.48-9.89; p0.001. Additionally, HALP score was found to be an indicator for in-hospital mortality 0.036. Conclusion: The HALP score proves to be a valuable predictive tool for NRP and in-hospital mortality in patients with presenting to the emergency department with ACS and undergoing SVG intervention.

 Aims: The no-reflow phenomenon NRP is one of the most frequently observed complications in saphenous vein graft SVG interventions. The aim of this study was to investigate the effect of the hemoglobin, albumin, lymphocyte, and platelet HALP score on the development of NRP in patients with acute coronary syndrome ACS undergoing percutaneous SVG intervention. Methods: This retrospective study included 263 patients who applied to our center with the diagnosis of ACS and underwent saphenous vein grafting procedure. The patients were divided into two groups according to whether no-reflow developed or not, and the HALP scores of the groups were compared. In addition, in-hospital mortality was compared between the study groups according to their HALP score values. The predictive ability of the HALP score for no-reflow was evaluated using a receiver operating characteristic curve. Results: NRP developed in 103 39.2 of the patients included in the study patients. HALP score value was found to be significantly lower in the no-reflow group 45.320 vs 53.818, p:0.001. In the receiver operating characteristic ROC analysis, the cutoff value for the HALP score was calculated as 46.5. After multivariable adjustment, the HALP score 46.5 was an independent predictor of no-reflow OR4.95, 95 CI:2.48-9.89; p0.001. Additionally, HALP score was found to be an indicator for in-hospital mortality 0.036. Conclusion: The HALP score proves to be a valuable predictive tool for NRP and in-hospital mortality in patients with presenting to the emergency department with ACS and undergoing SVG intervention.

 Aims: The no-reflow phenomenon NRP is one of the most frequently observed complications in saphenous vein graft SVG interventions. The aim of this study was to investigate the effect of the hemoglobin, albumin, lymphocyte, and platelet HALP score on the development of NRP in patients with acute coronary syndrome ACS undergoing percutaneous SVG intervention. Methods: This retrospective study included 263 patients who applied to our center with the diagnosis of ACS and underwent saphenous vein grafting procedure. The patients were divided into two groups according to whether no-reflow developed or not, and the HALP scores of the groups were compared. In addition, in-hospital mortality was compared between the study groups according to their HALP score values. The predictive ability of the HALP score for no-reflow was evaluated using a receiver operating characteristic curve. Results: NRP developed in 103 39.2 of the patients included in the study patients. HALP score value was found to be significantly lower in the no-reflow group 45.320 vs 53.818, p:0.001. In the receiver operating characteristic ROC analysis, the cutoff value for the HALP score was calculated as 46.5. After multivariable adjustment, the HALP score 46.5 was an independent predictor of no-reflow OR4.95, 95 CI:2.48-9.89; p0.001. Additionally, HALP score was found to be an indicator for in-hospital mortality 0.036. Conclusion: The HALP score proves to be a valuable predictive tool for NRP and in-hospital mortality in patients with presenting to the emergency department with ACS and undergoing SVG intervention.

 Aims: The no-reflow phenomenon NRP is one of the most frequently observed complications in saphenous vein graft SVG interventions. The aim of this study was to investigate the effect of the hemoglobin, albumin, lymphocyte, and platelet HALP score on the development of NRP in patients with acute coronary syndrome ACS undergoing percutaneous SVG intervention. Methods: This retrospective study included 263 patients who applied to our center with the diagnosis of ACS and underwent saphenous vein grafting procedure. The patients were divided into two groups according to whether no-reflow developed or not, and the HALP scores of the groups were compared. In addition, in-hospital mortality was compared between the study groups according to their HALP score values. The predictive ability of the HALP score for no-reflow was evaluated using a receiver operating characteristic curve. Results: NRP developed in 103 39.2 of the patients included in the study patients. HALP score value was found to be significantly lower in the no-reflow group 45.320 vs 53.818, p:0.001. In the receiver operating characteristic ROC analysis, the cutoff value for the HALP score was calculated as 46.5. After multivariable adjustment, the HALP score 46.5 was an independent predictor of no-reflow OR4.95, 95 CI:2.48-9.89; p0.001. Additionally, HALP score was found to be an indicator for in-hospital mortality 0.036. Conclusion: The HALP score proves to be a valuable predictive tool for NRP and in-hospital mortality in patients with presenting to the emergency department with ACS and undergoing SVG intervention.

Makale detayları

HALP score can predict the no-reflow phenomenon and in-hospital mortality after saphenous vein graft intervention

Yazarlar:

Ömer Furkan Demir | Barış Şensoy

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kardiyoloji

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

10/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001338821

pISSN:

2718-0115

HALP score

no-reflow phenomenon

saphenous vein graft

percutaneous coronary intervention

acute coronary syndrome

Sayı

Makale detayları

HALP score can predict the no-reflow phenomenon and in-hospital mortality after saphenous vein graft intervention

Yazarlar: Ömer Furkan Demir | Barış Şensoy

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Kardiyoloji

Dergi: Anatolian Current Medical Journal Vol.7 Issue 1, pp.1-7

Belge Tipi: Makale

Yayın Tarihi: 10/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001338821

pISSN: 2718-0115

HALP score

no-reflow phenomenon

saphenous vein graft

percutaneous coronary intervention

acute coronary syndrome

Sayı

Yazarlar:

Ömer Furkan Demir | Barış Şensoy

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Kardiyoloji

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 1, pp.1-7

Belge Tipi:

Makale

Yayın Tarihi:

10/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001338821

pISSN:

2718-0115